FDA scientists push back on an industry-funded analysis about bioaccumulation and toxicity of short-chain PFAS

Tom Neltner, J.D., Chemicals Policy Director and Maricel Maffini, Ph.D., Consultant Note to readers: As we all grapple with the grave global health challenge from COVID19, we want to acknowledge the essential services that professionals at the Food and Drug Administration (FDA) and in the food production, processing and retail industries provide in continuing to deliver … Continue reading FDA scientists push back on an industry-funded analysis about bioaccumulation and toxicity of short-chain PFAS